Related Experiment Video
Updated: Dec 29, 2025

Basophil Activation Test for Allergy Diagnosis
Published on: May 31, 2021
Unmet needs of children with peanut allergy: Aligning the risks and the evidence
Edmond S Chan1, Chitra Dinakar2, Erika Gonzales-Reyes3
1BC Children's Hospital, The University of British Columbia, Vancouver, Canada.
Insights
Effective peanut allergy prevention and management require addressing key unmet needs. Optimizing early introduction, improving immunotherapy knowledge translation, and clarifying exposure risks are crucial for evidence-based care.
Area of Science:
- Allergy and Immunology
- Pediatric Allergy
- Public Health
Background:
- Peanut allergy is a significant, lifelong health concern with limited treatment options.
- Current preventive strategies and management approaches for peanut allergy are insufficient.
Purpose of the Study:
- Convene experts to identify unmet needs in peanut allergy prevention and management.
- Highlight critical areas for research and clinical practice improvement.
- Inform evidence-based strategies for caregivers and healthcare providers.
Main Methods:
- Expert panel convened with allergists, pediatricians, and advocates.
- Systematic literature review of PubMed for relevant studies.
- Evaluation of data on peanut allergy prevention, treatment, and reaction management.
Main Results:
- Key unmet needs identified in optimizing early peanut introduction for prevention.
- Need for improved knowledge translation regarding immunotherapy safety and efficacy.
- Importance of understanding exposure risk and ensuring epinephrine access for severe reactions.
Conclusions:
- Significant gaps exist in peanut allergy understanding and management.
- Addressing unmet needs will enhance prevention and treatment strategies.
- Improved education on evidence-based practices is vital for the allergic community.
Background:
Peanut allergy is a potentially severe and lifelong allergy, with few effective treatments or preventive measures.
Objective:
To convene an expert panel of allergists, pediatricians, and advocates to discuss and highlight unmet needs in the prevention and management of peanut allergies.
Methods:
Literature searches of PubMed were performed. The panel evaluated published data on the prevention of peanut allergy, treatment of existing peanut allergy, and management of reactions after unintentional peanut exposures.
Results:
The following key unmet needs in the prevention and management of peanut allergy were identified: (1) enhancing and optimizing implementation of early peanut introduction as a means of preventing the development of peanut allergy, (2) developing knowledge translation strategies regarding the safety and efficacy data for current and emerging immunotherapies for peanut-allergic children to support their use in clinical practice, and (3) promoting understanding of true exposure risk in allergic individuals and ensuring access to epinephrine for unintentional exposures that provoke severe reactions. Practitioners should help educate caregivers about the actual risks associated with peanut allergy and its prevention and management so that treatment decisions can be evidence based rather than fear based. Support tools are needed to help address caregiver goals, expectations, and psychological barriers, as well as identify facilitators for prevention and treatment strategies.
Conclusion:
There are significant unmet needs in our understanding of peanut allergy; addressing these needs will help to enhance understanding of how to most effectively prevent and treat peanut allergy, as well as educate the food-allergic and nonallergic community regarding current evidence-based practices.
Related Concept Videos
Allergic Reactions
Cross-reactivity
Pharmacokinetics in Pediatric Patients: Drug Excretion
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...

